Literature DB >> 2310400

Isovalerylcarnitine is a specific activator of the high calcium requiring calpain forms.

S Pontremoli1, E Melloni, P L Viotti, M Michetti, F Di Lisa, N Siliprandi.   

Abstract

Isovalerylcarnitine, a product of the catabolism of L-leucine, is a potent activator of rat calpains isolated from erythrocytes, kidney, liver, skeletal and heart muscle. Only calpains II, but not calpains I, are activated by IVC, with the only exception of rat erythrocyte calpain I, the only species present in these cells which has a Ca2+ requirement higher than that of most calpain I isoenzymes. Activation by IVC involves a dual effect: 1) a ten fold increase in the affinity of calpain for Ca2+, and 2) an increase in the Vmax 1.3-1.6 fold above the values observed with the native enzymes at saturating [Ca2+] as well as with the autolyzed fully active calpain form at 5 microM Ca2+. The increased affinity for calcium results in an increased rate of autoproteolysis of calpain II. Activation by IVC is additive to that promoted by interaction (or association) to phospholipids vesicles. Together these results suggest that IVC may operate as a selective activator of calpain both in the cytosol and at the membrane level; in the latter case in synergism with the activation induced by association of the proteinase to the cell membrane.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2310400     DOI: 10.1016/0006-291x(90)91775-n

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

Review 1.  Calpain activity and muscle wasting in sepsis.

Authors:  Ira J Smith; Stewart H Lecker; Per-Olof Hasselgren
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-05-20       Impact factor: 4.310

2.  Integrative metabolome and transcriptome profiling reveals discordant energetic stress between mouse strains with differential sensitivity to acrolein-induced acute lung injury.

Authors:  James P Fabisiak; Mario Medvedovic; Danny C Alexander; Jonathan E McDunn; Vincent J Concel; Kiflai Bein; An Soo Jang; Annerose Berndt; Louis J Vuga; Kelly A Brant; Hannah Pope-Varsalona; Richard A Dopico; Koustav Ganguly; Swapna Upadhyay; Qian Li; Zhen Hu; Naftali Kaminski; George D Leikauf
Journal:  Mol Nutr Food Res       Date:  2011-08-08       Impact factor: 5.914

3.  Calcium-binding properties of human erythrocyte calpain.

Authors:  M Michetti; F Salamino; R Minafra; E Melloni; S Pontremoli
Journal:  Biochem J       Date:  1997-08-01       Impact factor: 3.857

4.  Analysis of serum metabolic profiles in women with endometrial cancer and controls in a population-based case-control study.

Authors:  Mia M Gaudet; Roni T Falk; Robert D Stevens; Marc J Gunter; James R Bain; Ruth M Pfeiffer; Nancy Potischman; Jolanta Lissowska; Beata Peplonska; Louise A Brinton; Montserrat Garcia-Closas; Christopher B Newgard; Mark E Sherman
Journal:  J Clin Endocrinol Metab       Date:  2012-06-22       Impact factor: 5.958

5.  Specific degradation of troponin T and I by mu-calpain and its modulation by substrate phosphorylation.

Authors:  F Di Lisa; R De Tullio; F Salamino; R Barbato; E Melloni; N Siliprandi; S Schiaffino; S Pontremoli
Journal:  Biochem J       Date:  1995-05-15       Impact factor: 3.857

6.  Site-directed activation of calpain is promoted by a membrane-associated natural activator protein.

Authors:  F Salamino; R De Tullio; P Mengotti; P L Viotti; E Melloni; S Pontremoli
Journal:  Biochem J       Date:  1993-02-15       Impact factor: 3.857

7.  PEST motifs are not required for rapid calpain-mediated proteolysis of c-fos protein.

Authors:  S Carillo; M Pariat; A m Steff; I Jariel-Encontre; F Poulat; P Berta; M Piechaczyk
Journal:  Biochem J       Date:  1996-01-01       Impact factor: 3.857

8.  Metabolomic profiling can predict which humans will develop liver dysfunction when deprived of dietary choline.

Authors:  Wei Sha; Kerry-Ann da Costa; Leslie M Fischer; Michael V Milburn; Kay A Lawton; Alvin Berger; Wei Jia; Steven H Zeisel
Journal:  FASEB J       Date:  2010-04-06       Impact factor: 5.191

9.  Proteinase treatment of intact hepatic mitochondria has differential effects on inhibition of carnitine palmitoyltransferase by different inhibitors.

Authors:  K Kashfi; G A Cook
Journal:  Biochem J       Date:  1992-03-15       Impact factor: 3.857

10.  Specific cleavage of transcription factors by the thiol protease, m-calpain.

Authors:  F Watt; P L Molloy
Journal:  Nucleic Acids Res       Date:  1993-11-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.